drugset
drugset / Trial / NCT03786809

Vascular Effect of CIMICIFUGA RACEMOSA

NCT03786809 ↗

Completed 60 enrolled Federal University of Minas Gerais
RandomizedParallel-groupTriple-blindTreatment

Summary

Postmenopausal women with vascular symptoms will use Cimifuga Racemosa or Placebo and the effects will be evaluated using Flow-Mediated Dilatation of the brachial artery.

Timeline

Start
2016-06
Primary completion
2019-04
Completion
2019-05

Drugs

EvaluationDrugModalityDoseRoute
Subject Cimifuga Racemosa Unknown 160 mg —

Indications

No indication recorded.